For research and laboratory use only. Not for human or animal consumption. Not intended for diagnostic, therapeutic, or clinical use.
KLOW Blend
KLOW Blend from Primeva Labs is offered strictly for research use only. Each order includes batch-specific CoA documentation, quality verification, and secure online ordering. Not for human or animal consumption.
Primeva Labs supplies materials strictly for laboratory and research use. Create a complimentary research account to view current pricing, availability, and ordering.
By creating an account you confirm you are 21+, agree to the Terms & Research-Use Disclaimer, and acknowledge these products are sold strictly for research use — not for human or animal consumption.
What Is KLOW Blend?
KLOW is a research blend combining GHK-Cu, BPC-157, TB-500, and KPV — pairing three repair-and-remodeling peptides with the anti-inflammatory tripeptide KPV.
- Co-formulated GHK-Cu + BPC-157 + TB-500 + KPV research blend
- Adds the alpha-MSH-derived anti-inflammatory tripeptide KPV
- Per-component assay reported on a batch-specific certificate
- Supplied strictly as a research-grade reference material
Research Applications
Tissue & inflammation research
Studied as a combination across repair, remodeling, and inflammation models.
Angiogenesis + remodeling
Examined for complementary new-vessel and matrix-remodeling effects.
Mucosal / gut-lining models
Investigated for KPV anti-inflammatory effects in epithelial research.
Synergy research
Explored for combined effects across four distinct pathways.
Proposed Mechanisms
GHK-Cu: ECM remodeling
Delivers copper and is studied for collagen and matrix remodeling.
BPC-157 + TB-500: repair
Contribute angiogenic, cytoprotective, and cell-migration signaling.
KPV: anti-inflammatory
An alpha-MSH C-terminal tripeptide studied for down-regulating inflammatory signaling.
Complementary action
The four are proposed to address distinct repair and inflammation stages.
Mechanisms described above are drawn from preclinical (cell and animal) research and, where noted, early clinical literature. They are provided for educational context and should not be read as clinical or therapeutic claims.
